Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.
Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.
Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.
The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday.
Several lots of two drugs used to treat anemia are being recalled due to possible...
Generic drug maker Dr. Reddy’s has launched in India the world’s first follow-on version of...
Biotech company Amgen had $3.8 billion in sales and $1.33 billion in profits during second...
Hospira had net sales of $968 million and profits of $83.5 million in second quarter...